Tuesday 10th September 2024 13:00 - 14:00 (BST)
At its core, the value proposition of pharmaceutical products is deeply entwined with their capacity to diagnose, treat and prevent diseases – a vital consideration in health technology appraisal (HTA).
In these assessments, a sharp focus is demanded on evidence demonstrating therapeutic value and economic benefits, with increasing focus on humanistic and societal value.
The innovation inherent in pharmaceuticals is also a focal point during these evaluations, reflecting the industry’s commitment to introducing novel therapies and treatment modalities that align with evolving healthcare needs.
Join us in this informative 60-minute masterclass for LSAA members and hear from experts at Initiate.
10th Sep 2024 13:00 – 14:00 (BST)